{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:55:57Z","timestamp":1790870157331,"version":"4.1.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06246-4","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:23:04Z","timestamp":1790864584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HTR3A Receptor Signaling in Human Disease: From Bioelectrical Regulation to Therapeutic Targeting"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4259-7672","authenticated-orcid":false,"given":"Ghasem","family":"Ahangari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-1070","authenticated-orcid":false,"given":"Fatemeh","family":"Abedini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9033-2416","authenticated-orcid":false,"given":"Shadi","family":"Ghaemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"9","key":"6246_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70383","volume":"6","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang N, Zhang L, Zhuang Y, Xin Q, Gu X, Jiang C, Wu J (2025) Serotonin (5-Hydroxytryptamine): metabolism, signaling, biological functions, diseases, and emerging therapeutic opportunities. MedComm 6(9):e70383","journal-title":"MedComm"},{"issue":"10","key":"6246_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.5483\/BMBRep.2023-0147","volume":"56","author":"A Parajulee","year":"2023","unstructured":"Parajulee A, Kim K (2023) Structural studies of serotonin receptor family. BMB Rep 56(10):527","journal-title":"BMB Rep"},{"issue":"48","key":"6246_CR3","doi-asserted-by":"publisher","first-page":"40239","DOI":"10.1074\/jbc.R112.406496","volume":"287","author":"SC Lummis","year":"2012","unstructured":"Lummis SC (2012) 5-HT3 receptors. J Biol Chem 287(48):40239\u201340245","journal-title":"J Biol Chem"},{"issue":"1","key":"6246_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/09687680110110048","volume":"19","author":"DC Reeves","year":"2002","unstructured":"Reeves DC, Lummis SC (2002) The molecular basis of the structure and function of the 5-HT 3 receptor: a model ligand-gated ion channel. Mol Membr Biol 19(1):11\u201326","journal-title":"Mol Membr Biol"},{"issue":"7","key":"6246_CR5","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1038\/s41401-026-01763-3","volume":"47","author":"Z-j Ye","year":"2026","unstructured":"Ye Z-j, Wu C-y, Zhang H, Zhang H-w, Vogel H (2026) The serotonin-gated 5-HT3 receptor: a tale of functions and structures of a prototypical pentameric ligand-gated ion channel. Acta Pharmacol Sin 47(7):1718\u20131732","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"6246_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neuropharm.2008.08.003","volume":"56","author":"NM Barnes","year":"2009","unstructured":"Barnes NM, Hales TG, Lummis SC, Peters JA (2009) The 5-HT3 receptor\u2013the relationship between structure and function. Neuropharmacology 56(1):273\u2013284","journal-title":"Neuropharmacology"},{"issue":"5","key":"6246_CR7","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.str.2016.03.019","volume":"24","author":"S Yuan","year":"2016","unstructured":"Yuan S, Filipek S, Vogel H (2016) A gating mechanism of the serotonin 5-HT3 receptor. Structure 24(5):816\u2013825","journal-title":"Structure"},{"issue":"21","key":"6246_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111910","volume":"22","author":"H Irving","year":"2021","unstructured":"Irving H, Turek I, Kettle C, Yaakob N (2021) Tapping into 5-HT3 receptors to modify metabolic and immune responses. Int J Mol Sci 22(21):11910","journal-title":"Int J Mol Sci"},{"issue":"12","key":"6246_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/jhg.2014.89","volume":"59","author":"Y-M Lin","year":"2014","unstructured":"Lin Y-M, Hsu C-D, Hsieh H-Y, Tseng C-CA, Sun HS (2014) Sequence variants of the HTR3A gene contribute to the genetic prediction of postoperative nausea in Taiwan. J Hum Genet 59(12):655\u2013660","journal-title":"J Hum Genet"},{"issue":"4","key":"6246_CR10","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1038\/tp.2012.30","volume":"2","author":"C Hammer","year":"2012","unstructured":"Hammer C, Cichon S, M\u00fchleisen T, Haenisch B, Degenhardt F, Mattheisen M, Breuer R, Witt S, et al. (2012) Replication of functional serotonin receptor type 3A and B variants in bipolar affective disorder: a European multicenter study. Transl Psychiatry 2(4):e103\u2013e103","journal-title":"Transl Psychiatry"},{"issue":"2","key":"6246_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1471-4159.2008.05775.x","volume":"108","author":"JD Holbrook","year":"2009","unstructured":"Holbrook JD, Gill CH, Zebda N, Spencer JP, Leyland R, Rance KH, Trinh H, Balmer G, et al. (2009) Characterisation of 5-HT3C, 5-HT3D and 5-HT3E receptor subunits: evolution, distribution and function. J Neurochem 108(2):384\u2013396","journal-title":"J Neurochem"},{"issue":"1","key":"6246_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep32564","volume":"6","author":"HW Kim","year":"2016","unstructured":"Kim HW, Kang JI, Lee S-H, An SK, Sohn SY, Hwang EH, Lee SY, Kim SJ (2016) Common variants of HTR3 genes are associated with obsessive-compulsive disorder and its phenotypic expression. Sci Rep 6(1):32564","journal-title":"Sci Rep"},{"issue":"48","key":"6246_CR13","doi-asserted-by":"publisher","first-page":"13151","DOI":"10.1523\/JNEUROSCI.3772-07.2007","volume":"27","author":"K Solt","year":"2007","unstructured":"Solt K, Ruesch D, Forman SA, Davies PA, Raines DE (2007) Differential effects of serotonin and dopamine on human 5-HT3A receptor kinetics: interpretation within an allosteric kinetic model. J Neurosci 27(48):13151\u201313160","journal-title":"J Neurosci"},{"key":"6246_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.11648\/j.ajbls.20241205.12","volume":"12","author":"T Yusifov","year":"2024","unstructured":"Yusifov T, Qudretova F, Aliyeva A (2024) Role of bioelectrical signaling networks in tumor growth. Am J Biomed Life Sci 12:83\u201392","journal-title":"Am J Biomed Life Sci"},{"issue":"5","key":"6246_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ceca.2005.01.011","volume":"37","author":"RD Fields","year":"2005","unstructured":"Fields RD, Lee PR, Cohen JE (2005) Temporal integration of intracellular Ca2+ signaling networks in regulating gene expression by action potentials. Cell Calcium 37(5):433\u2013442","journal-title":"Cell Calcium"},{"issue":"4","key":"6246_CR16","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1007\/s10528-024-10872-9","volume":"63","author":"Z Wu","year":"2025","unstructured":"Wu Z, Li J, Zhong M, Xu Z, Yang M, Xu C (2025) HTR3A promotes non-small cell lung cancer through the FOXH1\/Wnt3A signaling pathway. Biochem Genet 63(4):3554\u20133566","journal-title":"Biochem Genet"},{"key":"6246_CR17","unstructured":"Li M,\u00a0 Xiong\u00a0Z-G (2011) Ion channels as targets for cancer therapy. Int J Physiology Pathophysiology Pharmacol 3(2) 156"},{"issue":"12","key":"6246_CR18","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1016\/j.bpj.2020.10.029","volume":"119","author":"AG Stuebler","year":"2020","unstructured":"Stuebler AG, Jansen M (2020) Mobility of lower MA-helices for ion conduction through lateral portals in 5-HT3A receptors. Biophys J 119(12):2593\u20132603","journal-title":"Biophys J"},{"issue":"28","key":"6246_CR19","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.2174\/138161206778522029","volume":"12","author":"AJ Thompson","year":"2006","unstructured":"Thompson AJ, Lummis SR (2006) 5-HT3 receptors. Curr Pharm Des 12(28):3615\u20133630","journal-title":"Curr Pharm Des"},{"issue":"1","key":"6246_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.neuropharm.2008.06.063","volume":"56","author":"GL Collingridge","year":"2009","unstructured":"Collingridge GL, Olsen RW, Peters J, Spedding M (2009) A nomenclature for ligand-gated ion channels. Neuropharmacology 56(1):2\u20135","journal-title":"Neuropharmacology"},{"issue":"4","key":"6246_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1017\/S0033583510000168","volume":"43","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Lester HA, Lummis SC (2010) The structural basis of function in Cys-loop receptors. Q Rev Biophys 43(4):449\u2013499","journal-title":"Q Rev Biophys"},{"issue":"3","key":"6246_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.neuron.2016.03.032","volume":"90","author":"\u00c1 Nemecz","year":"2016","unstructured":"Nemecz \u00c1, Prevost MS, Menny A, Corringer P-J (2016) Emerging molecular mechanisms of signal transduction in pentameric ligand-gated ion channels. Neuron 90(3):452\u2013470","journal-title":"Neuron"},{"issue":"7514","key":"6246_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nature13552","volume":"512","author":"G Hassaine","year":"2014","unstructured":"Hassaine G, Deluz C, Grasso L, Wyss R, Tol MB, Hovius R, Graff A, Stahlberg H, et al. (2014) X-ray structure of the mouse serotonin 5-HT3 receptor. Nature 512(7514):276\u2013281","journal-title":"Nature"},{"issue":"7730","key":"6246_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-018-0660-7","volume":"563","author":"S Basak","year":"2018","unstructured":"Basak S, Gicheru Y, Rao S, Sansom MS, Chakrapani S (2018) Cryo-EM reveals two distinct serotonin-bound conformations of full-length 5-HT3A receptor. Nature 563(7730):270\u2013274","journal-title":"Nature"},{"issue":"6","key":"6246_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.tins.2004.04.004","volume":"27","author":"DA Doyle","year":"2004","unstructured":"Doyle DA (2004) Structural changes during ion channel gating. Trends Neurosci 27(6):298\u2013302","journal-title":"Trends Neurosci"},{"issue":"4","key":"6246_CR26","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1021\/acs.jcim.2c01441","volume":"63","author":"Z Li","year":"2023","unstructured":"Li Z, Chan KC, Nickels JD, Cheng X (2023) Molecular dynamics refinement of open state serotonin 5-HT3A receptor structures. J Chem Inf Model 63(4):1196\u20131207","journal-title":"J Chem Inf Model"},{"issue":"7730","key":"6246_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-018-0672-3","volume":"563","author":"L Polovinkin","year":"2018","unstructured":"Polovinkin L, Hassaine G, Perot J, Neumann E, Jensen AA, Lefebvre SN, Corringer P-J, Neyton J, et al. (2018) Conformational transitions of the serotonin 5-HT3 receptor. Nature 563(7730):275\u2013279","journal-title":"Nature"},{"issue":"2","key":"6246_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.resuscitation.2008.09.020","volume":"80","author":"C Cajavilca","year":"2009","unstructured":"Cajavilca C, Varon J, Sternbach GL (2009) Luigi Galvani and the foundations of electrophysiology. Resuscitation 80(2):159\u2013162","journal-title":"Resuscitation"},{"issue":"1","key":"6246_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1094428118804657","volume":"22","author":"RI Tivadar","year":"2019","unstructured":"Tivadar RI, Murray MM (2019) A primer on electroencephalography and event-related potentials for organizational neuroscience. Organ Res Methods 22(1):69\u201394","journal-title":"Organ Res Methods"},{"issue":"1","key":"6246_CR30","doi-asserted-by":"publisher","DOI":"10.3402\/jchimp.v2i1.14383","volume":"2","author":"M AlGhatrif","year":"2012","unstructured":"AlGhatrif M, Lindsay J (2012) A brief review: history to understand fundamentals of electrocardiography. J Community Hosp Intern Med Perspect 2(1):14383","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"2","key":"6246_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1085\/jgp.201711889","volume":"150","author":"C Franzini-Armstrong","year":"2018","unstructured":"Franzini-Armstrong C (2018) The relationship between form and function throughout the history of excitation\u2013contraction coupling. J Gen Physiol 150(2):189\u2013210","journal-title":"J Gen Physiol"},{"issue":"1","key":"6246_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304110","volume":"11","author":"R Moreddu","year":"2024","unstructured":"Moreddu R (2024) Nanotechnology and cancer bioelectricity: bridging the gap between biology and translational medicine. Adv Sci 11(1):2304110","journal-title":"Adv Sci"},{"issue":"6717","key":"6246_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/16941","volume":"397","author":"PA Davies","year":"1999","unstructured":"Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF (1999) The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 397(6717):359\u2013363","journal-title":"Nature"},{"issue":"5","key":"6246_CR34","first-page":"6100","volume":"16","author":"J Tang","year":"2018","unstructured":"Tang J, Wang Z, Liu J, Zhou C, Chen J (2018) Downregulation of 5-hydroxytryptamine receptor 3A expression exerts an anticancer activity against cell growth in colorectal carcinoma cells in vitro. Oncol Lett 16(5):6100\u20136108","journal-title":"Oncol Lett"},{"issue":"11","key":"6246_CR35","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tips.2005.09.011","volume":"26","author":"JA Peters","year":"2005","unstructured":"Peters JA, Hales TG, Jeremy JL (2005) Molecular determinants of single-channel conductance and ion selectivity in the Cys-loop family: insights from the 5-HT3 receptor. Trends Pharmacol Sci 26(11):587\u2013594","journal-title":"Trends Pharmacol Sci"},{"key":"6246_CR36","first-page":"541","volume-title":"Pharmacology of ionic channel function: activators and inhibitors","author":"J Yakel","year":"2000","unstructured":"Yakel J (2000) The 5-HT3 receptor channel: function, activation and regulation. Pharmacology of ionic channel function: activators and inhibitors. Springer, pp 541\u2013560"},{"issue":"1","key":"6246_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1042\/BST20210650","volume":"51","author":"M Marti-Solano","year":"2023","unstructured":"Marti-Solano M (2023) A multi-dimensional view of context-dependent G protein-coupled receptor function. Biochem Soc Trans 51(1):13\u201320","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"6246_CR38","doi-asserted-by":"publisher","first-page":"C762","DOI":"10.1152\/ajpcell.00113.2011","volume":"301","author":"A Arcangeli","year":"2011","unstructured":"Arcangeli A (2011) Ion channels and transporters in cancer. 3. Ion channels in the tumor cell-microenvironment cross talk. Am J Physiol Cell Physiol 301(4):C762\u2013C771","journal-title":"Am J Physiol Cell Physiol"},{"key":"6246_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.846917","volume":"12","author":"M Sheth","year":"2022","unstructured":"Sheth M, Esfandiari L (2022) Bioelectric dysregulation in cancer initiation, promotion, and progression. Front Oncol 12:846917","journal-title":"Front Oncol"},{"key":"6246_CR40","first-page":"151","volume-title":"Current topics in membranes","author":"MA Erdogan","year":"2023","unstructured":"Erdogan MA, Ugo DA, Ines F (2023) The role of ion channels in the relationship between the immune system and cancer. Current topics in membranes. Elsevier, pp 151\u2013198"},{"key":"6246_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.525020","volume":"11","author":"R Rapetti-Mauss","year":"2020","unstructured":"Rapetti-Mauss R, Berenguier C, Allegrini B, Soriani O (2020) Interplay between ion channels and the Wnt\/\u03b2-catenin signaling pathway in cancers. Front Pharmacol 11:525020","journal-title":"Front Pharmacol"},{"key":"6246_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2025.11.010","author":"WL Liu","year":"2025","unstructured":"Liu WL, Xie X, Chen H, Wan Y, Tang B, Mao W (2025) Targeting ion channel dysregulation in tumors: emerging therapeutic opportunities. Trends Pharmacol Sci. https:\/\/doi.org\/10.1016\/j.tips.2025.11.010","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"6246_CR43","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3390\/ph18101521","volume":"18","author":"S Zhou","year":"2025","unstructured":"Zhou S, Song X, Zeng W, Chen D (2025) Targeting ion channels for cancer therapy: from pathophysiological mechanisms to clinical translation. Pharmaceuticals (Basel) 18(10):1521","journal-title":"Pharmaceuticals (Basel)"},{"issue":"38","key":"6246_CR44","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.3748\/wjg.v25.i38.5732","volume":"25","author":"KJ Anderson","year":"2019","unstructured":"Anderson KJ, Cormier RT, Scott PM (2019) Role of ion channels in gastrointestinal cancer. World J Gastroenterol 25(38):5732","journal-title":"World J Gastroenterol"},{"issue":"6","key":"6246_CR45","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.bbamcr.2015.11.032","volume":"1863","author":"L Leanza","year":"2016","unstructured":"Leanza L, Manag\u00f2 A, Zoratti M, Gulbins E, Szabo I (2016) Pharmacological targeting of ion channels for cancer therapy: in vivo evidences. Biochim Biophys Acta 1863(6):1385\u20131397","journal-title":"Biochim Biophys Acta"},{"key":"6246_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.603480","volume":"10","author":"C Ji","year":"2020","unstructured":"Ji C, Sun L-S, Xing F, Niu N, Gao H-L, Dai J-W, Zhou N, Jiang B-C (2020) HTRA3 is a prognostic biomarker and associated with immune infiltrates in gastric cancer. Front Oncol 10:603480","journal-title":"Front Oncol"},{"issue":"7","key":"6246_CR47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1159\/000530878","volume":"101","author":"F Abedini","year":"2023","unstructured":"Abedini F, Amjadi O, Hedayatizadeh-Omran A, Lira SA, Ahangari G (2023) Serotonin receptors and acetylcholinesterase gene expression alternations: the potential value on tumor microenvironment of gastric cancer. Oncology 101(7):415\u2013424","journal-title":"Oncology"},{"issue":"1","key":"6246_CR48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11033-025-10474-7","volume":"52","author":"F Abedini","year":"2025","unstructured":"Abedini F, Amjadi O, Ahangari G (2025) Repurposing serotonergic drugs for gastric cancer: induction of apoptosis in vitro. Mol Biol Rep 52(1):373","journal-title":"Mol Biol Rep"},{"issue":"1","key":"6246_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-24414-9","volume":"15","author":"S Ghaemi","year":"2025","unstructured":"Ghaemi S, Abedini F, Mousavi A, Ahangari G (2025) Impact of pesticide diazinon on gastric cancer cell lines and the alteration of cholinergic and serotonergic pathway genes affecting cell proliferation. Sci Rep 15(1):40518","journal-title":"Sci Rep"},{"key":"6246_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.106015","volume":"136","author":"G-W Huang","year":"2021","unstructured":"Huang G-W, Chen Q-Q, Ma C-C, Xie L-H, Gu J (2021) Linc01305 promotes metastasis and proliferation of esophageal squamous cell carcinoma through interacting with IGF2BP2 and IGF2BP3 to stabilize HTR3A mRNA. Int J Biochem Cell Biol 136:106015","journal-title":"Int J Biochem Cell Biol"},{"issue":"9","key":"6246_CR51","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/2326-6066.CIR-20-1043","volume":"9","author":"T Li","year":"2021","unstructured":"Li T, Fu B, Zhang X, Zhou Y, Yang M, Cao M, Chen Y, Tan Y, et al. (2021) Overproduction of gastrointestinal 5-HT promotes colitis-associated colorectal cancer progression via enhancing NLRP3 inflammasome activation. Cancer Immunol Res 9(9):1008\u20131023","journal-title":"Cancer Immunol Res"},{"issue":"10","key":"6246_CR52","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1111\/cas.14592","volume":"111","author":"M Tone","year":"2020","unstructured":"Tone M, Tahara S, Nojima S, Motooka D, Okuzaki D, Morii E (2020) HTR3A is correlated with unfavorable histology and promotes proliferation through ERK phosphorylation in lung adenocarcinoma. Cancer Sci 111(10):3953\u20133961","journal-title":"Cancer Sci"},{"issue":"9","key":"6246_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091380","volume":"8","author":"JS Lee","year":"2019","unstructured":"Lee JS, Park SY, Kim NY, Kim DW, Oh JE, Heo E, Lee JS, Yoo YC (2019) Anti-tumor potential of a 5-HT3 receptor antagonist as a novel autophagy inducer in lung cancer: a retrospective clinical study with in vitro confirmation. J Clin Med 8(9):1380","journal-title":"J Clin Med"},{"key":"6246_CR54","first-page":"1","volume":"10","author":"S Razavi","year":"2022","unstructured":"Razavi S, Ahangari F, Abedini F, Rahimi B, Ahangari G (2022) A novel report of serotonin receptors antagonists inducing apoptosis in human lung carcinoma cells. J Cancer Res Ther Oncol 10:1\u201313","journal-title":"J Cancer Res Ther Oncol"},{"issue":"9","key":"6246_CR55","first-page":"5844","volume":"12","author":"R Li","year":"2020","unstructured":"Li R, Liu X, Zhou X-J, Chen X, Li J-P, Yin Y-H, Qu Y-Q (2020) Identification and validation of the prognostic value of immune-related genes in non-small cell lung cancer. Am J Transl Res 12(9):5844","journal-title":"Am J Transl Res"},{"issue":"11","key":"6246_CR56","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.7314\/APJCP.2014.15.11.4455","volume":"15","author":"SH Hejazi","year":"2014","unstructured":"Hejazi SH, Ahangari G, Pornour M, Deezagi A, Aminzadeh S, Ahmadkhaniha HR, Akbari ME (2014) Evaluation of gene expression changes of serotonin receptors, 5-HT3AR and 5-HT2AR as main stress factors in breast cancer patients. Asian Pac J Cancer Prev 15(11):4455\u20134458","journal-title":"Asian Pac J Cancer Prev"},{"key":"6246_CR57","first-page":"99","volume":"34","author":"Z Olfati","year":"2020","unstructured":"Olfati Z, Rigi G, Vaseghi H, Zamanzadeh Z, Sohrabi M, Hejazi SH (2020) Evaluation of serotonin receptors (5HTR2A and 5HTR3A) mRNA expression changes in tumor of breast cancer patients. Med J Islam Repub Iran 34:99","journal-title":"Med J Islam Repub Iran"},{"issue":"4","key":"6246_CR58","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/1570163813666151126215210","volume":"12","author":"SH Hejazi","year":"2015","unstructured":"Hejazi SH, Ahangari G, Deezagi A (2015) Alternative viewpoint against breast cancer based on selective serotonin receptors 5HTR3A and 5HTR2A antagonists that can mediate apoptosis in MCF-7 cell line. Curr Drug Discov Technol 12(4):240\u2013249","journal-title":"Curr Drug Discov Technol"},{"key":"6246_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1147189","volume":"13","author":"D Zhan","year":"2023","unstructured":"Zhan D, Wang X, Zheng Y, Wang S, Yang B, Pan B, Wang N, Wang Z (2023) Integrative dissection of 5-hydroxytryptamine receptors-related signature in the prognosis and immune microenvironment of breast cancer. Front Oncol 13:1147189","journal-title":"Front Oncol"},{"key":"6246_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.895428","volume":"13","author":"Y Xia","year":"2022","unstructured":"Xia Y, Jiang X, Huang Y, Liu Q, Huang Y, Zhang B, Mei Z, Xu D, et al. (2022) Construction of a tumor immune microenvironment-related prognostic model in BRAF-mutated papillary thyroid cancer. Front Endocrinol 13:895428","journal-title":"Front Endocrinol"},{"issue":"3","key":"6246_CR61","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s13577-020-00325-x","volume":"33","author":"C Wu","year":"2020","unstructured":"Wu C, Ma L, Wei H, Nie F, Ning J, Jiang T (2020) MiR-1256 inhibits cell proliferation and cell cycle progression in papillary thyroid cancer by targeting 5-hydroxy tryptamine receptor 3A. Hum Cell 33(3):630\u2013640","journal-title":"Hum Cell"},{"issue":"1","key":"6246_CR62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00204-024-03881-5","volume":"99","author":"X Liu","year":"2025","unstructured":"Liu X, Guo H, Kang M, Fu W, Li H, Ji H, Zhao J, Fang Y, et al. (2025) Multi-step gene set analysis identified HTR3 family genes involving childhood acute lymphoblastic leukemia susceptibility. Arch Toxicol 99(1):299\u2013307","journal-title":"Arch Toxicol"},{"key":"6246_CR63","unstructured":"Database of Single Nucleotide Polymorphisms (dbSNP) (2026) Bethesda (MD): National Center for BiotechnologyInformation, National Library of Medicine. dbSNP Build 157.\u00a0 Available from: https:\/\/www.ncbi.nlm.nih.gov\/snp\/"},{"key":"6246_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2024.106878","volume":"202","author":"R Choi","year":"2024","unstructured":"Choi R, Kim MJ, Ju HY, Lee JW, Lee S-Y (2024) Genetic polymorphisms and their association with methotrexate polyglutamates during maintenance treatment in Korean children and young adults with acute lymphoblastic leukemia. Eur J Pharm Sci 202:106878","journal-title":"Eur J Pharm Sci"},{"key":"6246_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2016.04.005","volume":"28","author":"CM Henstridge","year":"2016","unstructured":"Henstridge CM, Pickett E, Spires-Jones TL (2016) Synaptic pathology: a shared mechanism in neurological disease. Ageing Res Rev 28:72\u201384","journal-title":"Ageing Res Rev"},{"key":"6246_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2010.00144","volume":"4","author":"JB Rowe","year":"2010","unstructured":"Rowe JB (2010) Connectivity analysis is essential to understand neurological disorders. Front Syst Neurosci 4:144","journal-title":"Front Syst Neurosci"},{"issue":"11","key":"6246_CR67","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3390\/ph17111462","volume":"17","author":"Y Li","year":"2024","unstructured":"Li Y, Fu J, Wang H (2024) Advancements in targeting ion channels for the treatment of neurodegenerative diseases. Pharmaceuticals (Basel) 17(11):1462","journal-title":"Pharmaceuticals (Basel)"},{"key":"6246_CR68","doi-asserted-by":"publisher","DOI":"10.2147\/DNND.S370278","author":"F Fan","year":"2022","unstructured":"Fan F, Han F, Hao L (2022) Mechanisms of action of Semen Ziziphi spinosae in the treatment of Tourette syndrome. Degener Neurol Neuromuscul Dis. https:\/\/doi.org\/10.2147\/DNND.S370278","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"4","key":"6246_CR69","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00041444-200512000-00015","volume":"15","author":"B Niesler","year":"2005","unstructured":"Niesler B, Frank B, Hebebrand J, Rappold G (2005) Serotonin receptor genes HTR3A and HTR3B are not involved in Gilles de la Tourette syndrome. Psychiatr Genet 15(4):303\u2013304","journal-title":"Psychiatr Genet"},{"key":"6246_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2024.137816","volume":"832","author":"W Chen","year":"2024","unstructured":"Chen W, Zhang T, Zhang H (2024) Genes related to neurotransmitter receptors as potential biomarkers for Alzheimer\u2019s disease. Neurosci Lett 832:137816","journal-title":"Neurosci Lett"},{"key":"6246_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1129773","volume":"17","author":"D-D Wu","year":"2023","unstructured":"Wu D-D, Cheng J, Zheng Y-N, Liu Y-T, Hou S-X, Liu L-F, Huang L, Yuan Q-L (2023) Neuroplastin 65 deficiency reduces amyloid plaque formation and cognitive deficits in an Alzheimer\u2019s disease mouse model. Front Cell Neurosci 17:1129773","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"6246_CR72","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.4103\/1673-5374.366492","volume":"18","author":"L-F Liu","year":"2023","unstructured":"Liu L-F, Liu Y-T, Wu D-D, Cheng J, Li N-N, Zheng Y-N, Huang L, Yuan Q-L (2023) Inhibiting 5-hydroxytryptamine receptor 3 alleviates pathological changes of a mouse model of Alzheimer\u2019s disease. Neural Regen Res 18(9):2019\u20132028","journal-title":"Neural Regen Res"},{"key":"6246_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04716","author":"M Neshan","year":"2020","unstructured":"Neshan M, Campbell A, Malakouti SK, Zareii M, Ahangari G (2020) Gene expression of serotonergic markers in peripheral blood mononuclear cells of patients with late-onset Alzheimer\u2019s disease. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04716","journal-title":"Heliyon"},{"issue":"1","key":"6246_CR74","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/19768354.2024.2348671","volume":"28","author":"B Kim","year":"2024","unstructured":"Kim B, Hong S, Lee J, Kang S, Kim J-S, Jung C, Shin T, Youn B, et al. (2024) Identifying candidate genes associated with hippocampal dysfunction in a hemiparkinsonian rat model by transcriptomic profiling. Anim Cells Syst 28(1):198\u2013215","journal-title":"Anim Cells Syst"},{"key":"6246_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.172914","volume":"871","author":"C Kwan","year":"2020","unstructured":"Kwan C, Frouni I, B\u00e9dard D, Hamadjida A, Huot P (2020) Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson\u2019s disease. Eur J Pharmacol 871:172914","journal-title":"Eur J Pharmacol"},{"key":"6246_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108386","volume":"182","author":"C Kwan","year":"2021","unstructured":"Kwan C, Nuara SG, Bedard D, Gaudette F, Gourdon JC, Beaudry F, Huot P (2021) Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmoset. Neuropharmacology 182:108386","journal-title":"Neuropharmacology"},{"issue":"6","key":"6246_CR77","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1007\/s12602-024-10335-y","volume":"17","author":"L-K Bu","year":"2025","unstructured":"Bu L-K, Jia P-P, Huo W-B, Pei D-S (2025) Assessment of probiotics\u2019 impact on neurodevelopmental and behavioral responses in zebrafish models: implications for autism spectrum disorder therapy. Probiotics Antimicrob Proteins 17(6):3944\u20133959","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"6","key":"6246_CR78","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s12031-022-01994-z","volume":"72","author":"Y Qin","year":"2022","unstructured":"Qin Y, Cao L, Zhang J, Zhang H, Cai S, Guo B, Wu F, Zhao L, et al. (2022) Whole-transcriptome analysis of serum L1CAM-captured extracellular vesicles reveals neural and glycosylation changes in autism spectrum disorder. J Mol Neurosci 72(6):1274\u20131292","journal-title":"J Mol Neurosci"},{"issue":"19","key":"6246_CR79","doi-asserted-by":"publisher","first-page":"9296","DOI":"10.7150\/thno.60531","volume":"11","author":"L Huang","year":"2021","unstructured":"Huang L, Wang J, Liang G, Gao Y, Jin S-Y, Hu J, Yang X, Lao J, et al. (2021) Upregulated NMDAR-mediated GABAergic transmission underlies autistic-like deficits in Htr3a knockout mice. Theranostics 11(19):9296","journal-title":"Theranostics"},{"issue":"16","key":"6246_CR80","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033625","volume":"102","author":"C Zhang","year":"2023","unstructured":"Zhang C, Gai J, Fan X, Lei J, Tang J (2023) Exploring the molecular mechanism of Nux Vomica in treating ischemic stroke using network pharmacology and molecular docking methods. Medicine (Baltimore) 102(16):e33625","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"6246_CR81","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0014-2999(92)94817-F","volume":"224","author":"Y Kagami-ishi","year":"1992","unstructured":"Kagami-ishi Y, Shibata S, Watanabe S (1992) Neuroprotective effect of 5-HT3 receptor antagonist on ischemia-induced decrease in CA1 field potential in rat hippocampal slices. Eur J Pharmacol 224(1):51\u201356","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"6246_CR82","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2202-9-19","volume":"9","author":"E Candelario-Jalil","year":"2008","unstructured":"Candelario-Jalil E, Mu\u00f1oz E, Fiebich BL (2008) Detrimental effects of tropisetron on permanent ischemic stroke in the rat. BMC Neurosci 9(1):19","journal-title":"BMC Neurosci"},{"issue":"3","key":"6246_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13030471","volume":"13","author":"Y Teng","year":"2023","unstructured":"Teng Y, Sandhu A, Liemburg EJ, Naderi E, Alizadeh BZ (2023) The progress and pitfalls of pharmacogenetics-based precision medicine in schizophrenia spectrum disorders: a systematic review and meta-analysis. J Pers Med 13(3):471","journal-title":"J Pers Med"},{"issue":"5","key":"6246_CR84","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/YPG.0000000000000320","volume":"32","author":"MZ van Der Horst","year":"2022","unstructured":"van Der Horst MZ, Papadimitriou G, Luykx JJ (2022) Genetic determinants associated with response to clozapine in schizophrenia: an umbrella review. Psychiatr Genet 32(5):163\u2013170","journal-title":"Psychiatr Genet"},{"issue":"3","key":"6246_CR85","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/jpm11030181","volume":"11","author":"DZ Paderina","year":"2021","unstructured":"Paderina DZ, Boiko AS, Pozhidaev IV, Bocharova AV, Mednova IA, Fedorenko OY, Kornetova EG, Loonen AJ, et al. (2021) Genetic polymorphisms of 5-HT receptors and antipsychotic-induced metabolic dysfunction in patients with schizophrenia. J Pers Med 11(3):181","journal-title":"J Pers Med"},{"issue":"9","key":"6246_CR86","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1176\/appi.ajp.2013.12091163","volume":"170","author":"BA Johnson","year":"2013","unstructured":"Johnson BA, Seneviratne C, Wang X-Q, Ait-Daoud N, Li MD (2013) Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT3 antagonist ondansetron. Am J Psychiatry 170(9):1020\u20131031","journal-title":"Am J Psychiatry"},{"issue":"27","key":"6246_CR87","doi-asserted-by":"publisher","first-page":"6460","DOI":"10.1523\/JNEUROSCI.5261-04.2005","volume":"25","author":"T Iidaka","year":"2005","unstructured":"Iidaka T, Ozaki N, Matsumoto A, Nogawa J, Kinoshita Y, Suzuki T, Iwata N, Yamamoto Y, et al. (2005) A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala. J Neurosci 25(27):6460\u20136466","journal-title":"J Neurosci"},{"issue":"10","key":"6246_CR88","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/archpsyc.60.10.1017","volume":"60","author":"J Melke","year":"2003","unstructured":"Melke J, Westberg L, Nilsson S, Land\u00e9n M, Soderstrom H, Baghaei F, Rosmond R, Holm G, et al. (2003) A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women. Arch Gen Psychiatry 60(10):1017\u20131023","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"6246_CR89","first-page":"85","volume":"37","author":"HL Wang","year":"2024","unstructured":"Wang HL, Xue YF, Cui BQ, Liu H, Shen XX (2024) Risk factors of depression screened by two-sample Mendelian randomization analysis: a systematic review. Biomed Environ Sci 37(1):85\u201395","journal-title":"Biomed Environ Sci"},{"key":"6246_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18369","author":"H Zhou","year":"2023","unstructured":"Zhou H, Wang K, Xu Z, Liu D, Wang Y, Guo M (2023) Chronic unpredictable stress induces depression\/anxiety-related behaviors and alterations of hippocampal monoamine receptor mRNA expression in female mice at different ages. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18369","journal-title":"Heliyon"},{"key":"6246_CR91","doi-asserted-by":"publisher","first-page":"147564","DOI":"10.1016\/j.gene.2023.147564","volume":"877","author":"B Li","year":"2023","unstructured":"Li B, Zhao Y, Zhou X, Peng C, Yan X, Zou T (2023) Geniposide improves depression by promoting the expression of synapse-related proteins through the Creb1\/Six3os1 axis. Gene 877:147564","journal-title":"Gene"},{"issue":"9","key":"6246_CR92","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2174\/1386207325666220831152959","volume":"26","author":"L Chen","year":"2023","unstructured":"Chen L, Ye T, Wang X, Han L, Wang T, Qi D, Cheng X (2023) The mechanisms underlying the pharmacological effects of Guipi decoction on major depressive disorder based on network pharmacology and molecular docking. Comb Chem High Throughput Screen 26(9):1701\u20131728","journal-title":"Comb Chem High Throughput Screen"},{"issue":"12","key":"6246_CR93","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2217\/epi-2021-0015","volume":"13","author":"L Hjort","year":"2021","unstructured":"Hjort L, Rushiti F, Wang S-J, Fransquet P, Krasniqi SP, \u00c7arkaxhiu SI, Arifaj D, Xhemaili VD, et al. (2021) Intergenerational effects of maternal post-traumatic stress disorder on offspring epigenetic patterns and cortisol levels. Epigenomics 13(12):967\u2013980","journal-title":"Epigenomics"},{"issue":"2","key":"6246_CR94","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1365-2249.2007.03492.x","volume":"150","author":"G Menard","year":"2007","unstructured":"Menard G, Turmel V, Bissonnette E (2007) Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2. Clin Exp Immunol 150(2):340\u2013348","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"6246_CR95","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2174\/18715281113129990041","volume":"12","author":"G Ahangari","year":"2013","unstructured":"Ahangari G, Mohammadi Amirabad L, Mozafari S, Majeidi A, Derkhshan Deilami G (2013) Investigation of 5-HT3A receptor gene expression in peripheral blood mononuclear cells of individuals who had been exposed to air pollution. Inflamm Allergy Drug Targets 12(6):433\u2013438","journal-title":"Inflamm Allergy Drug Targets"},{"key":"6246_CR96","unstructured":"L.M. Amirabad, G. Ahangari, G.D. Deilami, (2014) Significant changes of 5-Hydroxytriptamine 3A receptor gene expression in peripheral blood mononuclear cells of allergic asthmatic patients. Iranian J Allergy Asthma Immunol\u00a013(1)33\u201339."},{"issue":"6","key":"6246_CR97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2312861121","volume":"121","author":"Z Huang","year":"2024","unstructured":"Huang Z, Zhang Y, Wang S, Qi R, Tao Y, Sun Y, Jiang D, Jiang X, et al. (2024) FOXD3-mediated transactivation of ALKBH5 promotes neuropathic pain via m6A-dependent stabilization of 5-HT3A mRNA in sensory neurons. Proc Natl Acad Sci U S A 121(6):e2312861121","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"6246_CR98","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/j.pain.0000000000002481","volume":"163","author":"JM Wotton","year":"2022","unstructured":"Wotton JM, Peterson E, Flenniken AM, Bains RS, Veeraragavan S, Bower LR, Bubier JA, Parisien M, et al. (2022) Identifying genetic determinants of inflammatory pain in mice using a large-scale gene-targeted screen. Pain 163(6):1139\u20131157","journal-title":"Pain"},{"issue":"21","key":"6246_CR99","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.3748\/wjg.v28.i21.2334","volume":"28","author":"S Berens","year":"2022","unstructured":"Berens S, Dong Y, Fritz N, Walstab J, D\u2019Amato M, Zheng T, Wahl V, Boekstegers F, et al. (2022) Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: a multicenter retrospective study. World J Gastroenterol 28(21):2334","journal-title":"World J Gastroenterol"},{"issue":"2","key":"6246_CR100","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/jpm12020142","volume":"12","author":"T Zhao","year":"2022","unstructured":"Zhao T, Zhang Y, Lee J, Starkweather AR, Young EE, Cong X (2022) The associations of single nucleotide polymorphisms with risk and symptoms of irritable bowel syndrome. J Pers Med 12(2):142","journal-title":"J Pers Med"},{"issue":"2","key":"6246_CR101","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/1721727X1301100221","volume":"11","author":"S Ghasemi","year":"2013","unstructured":"Ghasemi S, Ahangari G, Mortazavi H, Mohamadian M (2013) Inflammatory mediator serotonin receptor (5-HT3AR) gene encoding analysis in patients with psoriasis vulgaris. Eur J Inflamm 11(2):521\u2013526","journal-title":"Eur J Inflamm"},{"issue":"2","key":"6246_CR102","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/1721727X1000800205","volume":"8","author":"MS Koupaei","year":"2010","unstructured":"Koupaei MS, Ahangari G, Samanguiei S (2010) Inflammatory mediator serotonin receptor gene (5-HTR3A) expression changes on human peripheral blood lymphocytes in rheumatoid arthritis. Eur J Inflamm 8(2):83\u201388","journal-title":"Eur J Inflamm"},{"issue":"4","key":"6246_CR103","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2165\/00003495-199142040-00002","volume":"42","author":"MS Aapro","year":"1991","unstructured":"Aapro MS (1991) 5-HT3 receptor antagonists: an overview of their present status and future potential in cancer therapy-induced emesis. Drugs 42(4):551\u2013568","journal-title":"Drugs"},{"issue":"4","key":"6246_CR104","first-page":"232","volume":"5","author":"KV Rao","year":"2012","unstructured":"Rao KV, Faso A (2012) Chemotherapy-induced nausea and vomiting: optimizing prevention and management. Am Health Drug Benefits 5(4):232","journal-title":"Am Health Drug Benefits"},{"issue":"10","key":"6246_CR105","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1002\/2211-5463.12944","volume":"10","author":"GB Lv","year":"2020","unstructured":"Lv GB, Wang TT, Zhu HL, Wang HK, Sun W, Zhao LF (2020) Vortioxetine induces apoptosis and autophagy of gastric cancer AGS cells via the PI3K\/AKT pathway. FEBS Open Bio 10(10):2157\u20132165","journal-title":"FEBS Open Bio"},{"issue":"8","key":"6246_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/toxics11080669","volume":"11","author":"R Gor","year":"2023","unstructured":"Gor R, Gharib A, Dharshini Balaji P, Madhavan T, Ramalingam S (2023) Inducing cytotoxicity in colon cancer cells and suppressing cancer stem cells by dolasetron and ketoprofen through inhibition of RNA binding protein PUM1. Toxics 11(8):669","journal-title":"Toxics"},{"issue":"7","key":"6246_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1750","volume":"14","author":"L Chen","year":"2024","unstructured":"Chen L, Huang S, Wu X, He W, Song M (2024) Serotonin signalling in cancer: emerging mechanisms and therapeutic opportunities. Clin Transl Med 14(7):e1750","journal-title":"Clin Transl Med"},{"issue":"5","key":"6246_CR108","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/j.1476-5381.1996.tb15529.x","volume":"118","author":"AG Hope","year":"1996","unstructured":"Hope AG, Peters JA, Brown AM, Lambert JJ, Blackburn TP (1996) Characterization of a human 5\u2010hydroxytryptamine3 receptor type A (h5\u2010HT3R\u2010AS) subunit stably expressed in HEK 293 cells. Br J Pharmacol 118(5):1237\u20131245","journal-title":"Br J Pharmacol"},{"issue":"43","key":"6246_CR109","doi-asserted-by":"publisher","first-page":"30799","DOI":"10.1074\/jbc.274.43.30799","volume":"274","author":"AE Dubin","year":"1999","unstructured":"Dubin AE, Huvar R, D\u2019Andrea MR, Pyati J, Zhu JY, Joy KC, Wilson SJ, Galindo JE, et al. (1999) The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit. J Biol Chem 274(43):30799\u201330810","journal-title":"J Biol Chem"},{"issue":"2-3","key":"6246_CR110","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0922-4106(90)90026-T","volume":"189","author":"SC Lummis","year":"1990","unstructured":"Lummis SC, Kilpatrick GJ, Martin IL (1990) Characterization of 5-HT3 receptors in intact N1E-115 neuroblastoma cells. Eur J Pharmacol 189(2\u20133):223\u2013227","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"6246_CR111","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/jcb.29395","volume":"121","author":"M Rashidi","year":"2020","unstructured":"Rashidi M, Bazi A, Shiran MR, Bagheri A, Mehrabadi AR, Kalantar H, Ghafouri Z, Hosseini SM (2020) Tropisetron attenuates tumor growth and progression in an experimental model of mouse lung cancer. J Cell Biochem 121(2):1610\u20131622","journal-title":"J Cell Biochem"},{"issue":"8","key":"6246_CR112","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jama.284.8.963","volume":"284","author":"BA Johnson","year":"2000","unstructured":"Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, et al. (2000) Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial. JAMA 284(8):963\u2013971","journal-title":"JAMA"},{"issue":"Suppl 7","key":"6246_CR113","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2036.2004.02180.x","volume":"20","author":"MD Gershon","year":"2004","unstructured":"Gershon MD (2004) Review article: serotonin receptors and transporters \u2013 roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 20(Suppl 7):3\u201314","journal-title":"Aliment Pharmacol Ther"},{"key":"6246_CR114","unstructured":"J. Theriot,\u00a0HR. Wermuth,\u00a0JV (2024) Antiemetics, Selective 5-HT3 Antagonists.\u00a0In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing"},{"issue":"1","key":"6246_CR115","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.intimp.2014.06.003","volume":"22","author":"C Stratz","year":"2014","unstructured":"Stratz C, Anakwue J, Bhatia H, Pitz S, Fiebich BL (2014) Anti-inflammatory effects of 5-HT3 receptor antagonists in interleukin-1beta stimulated primary human chondrocytes. Int Immunopharmacol 22(1):160\u2013166","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"6246_CR116","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0028-3908(89)90040-3","volume":"28","author":"J Giordano","year":"1989","unstructured":"Giordano J, Dyche J (1989) Differential analgesic actions of serotonin 5-HT3 receptor antagonists in the mouse. Neuropharmacology 28(4):423\u2013427","journal-title":"Neuropharmacology"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06246-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:09:01Z","timestamp":1790867341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06246-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6246"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06246-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"19 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study is a narrative review based exclusively on previously published literature and did not involve human participants, human tissues, animals, or identifiable personal data.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"941"}}